BRANDON TIBBITTS: Open Payments
NPI 1205276474 · WETHERSFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 38 payments from 11 companies in 2025. Trend: 2023 $1,587 · 2024 $1,159 · 2025 $1,134
Food & beverage: $1,065Education: $69
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $223 |
| ABBVIE INC. | 12 | $169 |
| Janssen Biotech, Inc. | 5 | $153 |
| Incyte Corporation | 3 | $137 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $92 |
| GENZYME CORPORATION | 2 | $71 |
| Amgen Inc. | 2 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Organon LLC | 2 | $40 |
Products named: Bimzelx, TREMFYA, OPZELURA, DUPIXENT, Leqselvi, RINVOQ, SKYRIZI, COSENTYX.
Industry payments across CT — which companies pay providers there.
